NCT01872026View on ClinicalTrials.gov

Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 26, 2012

Primary Completion Date

June 26, 2013

Study Completion Date

June 26, 2013

Conditions
Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis TherapyPharmacodynamics of ASP7991Pharmacokinetics of ASP7991
Interventions
DRUG

ASP7991

oral

Trial Locations (1)

Unknown

Kantou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY